nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—Alzheimer's disease	0.355	1	CbGaD
Ranolazine—CYP2D6—Rivastigmine—Alzheimer's disease	0.114	0.264	CbGbCtD
Ranolazine—CYP2D6—Donepezil—Alzheimer's disease	0.0909	0.211	CbGbCtD
Ranolazine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0723	0.168	CbGbCtD
Ranolazine—CYP2D6—Galantamine—Alzheimer's disease	0.0586	0.136	CbGbCtD
Ranolazine—CYP3A4—Donepezil—Alzheimer's disease	0.0578	0.134	CbGbCtD
Ranolazine—CYP3A4—Galantamine—Alzheimer's disease	0.0372	0.0865	CbGbCtD
Ranolazine—Diplopia—Memantine—Alzheimer's disease	0.000767	0.00397	CcSEcCtD
Ranolazine—Pain in extremity—Memantine—Alzheimer's disease	0.000767	0.00397	CcSEcCtD
Ranolazine—Cramp muscle—Donepezil—Alzheimer's disease	0.000761	0.00394	CcSEcCtD
Ranolazine—Pain in extremity—Rivastigmine—Alzheimer's disease	0.000751	0.00388	CcSEcCtD
Ranolazine—Diplopia—Rivastigmine—Alzheimer's disease	0.000751	0.00388	CcSEcCtD
Ranolazine—Hallucination—Galantamine—Alzheimer's disease	0.00075	0.00388	CcSEcCtD
Ranolazine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000745	0.00385	CcSEcCtD
Ranolazine—Oedema peripheral—Galantamine—Alzheimer's disease	0.000743	0.00384	CcSEcCtD
Ranolazine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000741	0.00383	CcSEcCtD
Ranolazine—Urethral disorder—Galantamine—Alzheimer's disease	0.000739	0.00382	CcSEcCtD
Ranolazine—Urinary retention—Memantine—Alzheimer's disease	0.00073	0.00377	CcSEcCtD
Ranolazine—Visual impairment—Galantamine—Alzheimer's disease	0.000727	0.00376	CcSEcCtD
Ranolazine—Eosinophilia—Donepezil—Alzheimer's disease	0.000723	0.00374	CcSEcCtD
Ranolazine—Blood creatinine increased—Memantine—Alzheimer's disease	0.000719	0.00372	CcSEcCtD
Ranolazine—Pancreatitis—Donepezil—Alzheimer's disease	0.000716	0.0037	CcSEcCtD
Ranolazine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000714	0.00369	CcSEcCtD
Ranolazine—Dehydration—Memantine—Alzheimer's disease	0.000713	0.00369	CcSEcCtD
Ranolazine—Eye disorder—Galantamine—Alzheimer's disease	0.000705	0.00365	CcSEcCtD
Ranolazine—Tinnitus—Galantamine—Alzheimer's disease	0.000703	0.00364	CcSEcCtD
Ranolazine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000701	0.00362	CcSEcCtD
Ranolazine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.0007	0.00362	CcSEcCtD
Ranolazine—Cardiac disorder—Galantamine—Alzheimer's disease	0.0007	0.00362	CcSEcCtD
Ranolazine—Dehydration—Rivastigmine—Alzheimer's disease	0.000698	0.00361	CcSEcCtD
Ranolazine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000685	0.00355	CcSEcCtD
Ranolazine—Angiopathy—Galantamine—Alzheimer's disease	0.000684	0.00354	CcSEcCtD
Ranolazine—Dysuria—Donepezil—Alzheimer's disease	0.000683	0.00353	CcSEcCtD
Ranolazine—Breast disorder—Rivastigmine—Alzheimer's disease	0.000678	0.00351	CcSEcCtD
Ranolazine—SCN9A—L1CAM interactions—DPYSL2—Alzheimer's disease	0.000676	0.0357	CbGpPWpGaD
Ranolazine—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000676	0.0035	CcSEcCtD
Ranolazine—Arrhythmia—Galantamine—Alzheimer's disease	0.000674	0.00348	CcSEcCtD
Ranolazine—Mental disorder—Galantamine—Alzheimer's disease	0.000661	0.00342	CcSEcCtD
Ranolazine—Weight decreased—Donepezil—Alzheimer's disease	0.000661	0.00342	CcSEcCtD
Ranolazine—Malnutrition—Galantamine—Alzheimer's disease	0.000657	0.0034	CcSEcCtD
Ranolazine—Pancreatitis—Memantine—Alzheimer's disease	0.00065	0.00336	CcSEcCtD
Ranolazine—Flatulence—Galantamine—Alzheimer's disease	0.000647	0.00335	CcSEcCtD
Ranolazine—Renal failure—Donepezil—Alzheimer's disease	0.00064	0.00331	CcSEcCtD
Ranolazine—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000636	0.00329	CcSEcCtD
Ranolazine—Muscle spasms—Galantamine—Alzheimer's disease	0.000631	0.00326	CcSEcCtD
Ranolazine—Pancytopenia—Memantine—Alzheimer's disease	0.00063	0.00326	CcSEcCtD
Ranolazine—Carvedilol—VEGFA—Alzheimer's disease	0.000622	0.29	CrCbGaD
Ranolazine—Haematuria—Donepezil—Alzheimer's disease	0.000621	0.00321	CcSEcCtD
Ranolazine—Dysuria—Memantine—Alzheimer's disease	0.00062	0.00321	CcSEcCtD
Ranolazine—Vision blurred—Galantamine—Alzheimer's disease	0.000619	0.0032	CcSEcCtD
Ranolazine—Tremor—Galantamine—Alzheimer's disease	0.000615	0.00318	CcSEcCtD
Ranolazine—Epistaxis—Donepezil—Alzheimer's disease	0.000614	0.00318	CcSEcCtD
Ranolazine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000611	0.00316	CcSEcCtD
Ranolazine—Dysuria—Rivastigmine—Alzheimer's disease	0.000607	0.00314	CcSEcCtD
Ranolazine—Weight decreased—Memantine—Alzheimer's disease	0.0006	0.0031	CcSEcCtD
Ranolazine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000597	0.00309	CcSEcCtD
Ranolazine—Bradycardia—Donepezil—Alzheimer's disease	0.000595	0.00308	CcSEcCtD
Ranolazine—Vertigo—Galantamine—Alzheimer's disease	0.00059	0.00305	CcSEcCtD
Ranolazine—Syncope—Galantamine—Alzheimer's disease	0.000589	0.00305	CcSEcCtD
Ranolazine—Weight decreased—Rivastigmine—Alzheimer's disease	0.000587	0.00304	CcSEcCtD
Ranolazine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000582	0.00301	CcSEcCtD
Ranolazine—Hallucination—Donepezil—Alzheimer's disease	0.000582	0.00301	CcSEcCtD
Ranolazine—Renal failure—Memantine—Alzheimer's disease	0.000581	0.00301	CcSEcCtD
Ranolazine—Palpitations—Galantamine—Alzheimer's disease	0.00058	0.003	CcSEcCtD
Ranolazine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000577	0.00299	CcSEcCtD
Ranolazine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000577	0.00298	CcSEcCtD
Ranolazine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000576	0.00298	CcSEcCtD
Ranolazine—Urethral disorder—Donepezil—Alzheimer's disease	0.000573	0.00296	CcSEcCtD
Ranolazine—Cough—Galantamine—Alzheimer's disease	0.000573	0.00296	CcSEcCtD
Ranolazine—Renal failure—Rivastigmine—Alzheimer's disease	0.000569	0.00294	CcSEcCtD
Ranolazine—Haematuria—Memantine—Alzheimer's disease	0.000564	0.00292	CcSEcCtD
Ranolazine—Visual impairment—Donepezil—Alzheimer's disease	0.000563	0.00291	CcSEcCtD
Ranolazine—Epistaxis—Memantine—Alzheimer's disease	0.000558	0.00288	CcSEcCtD
Ranolazine—Anxiety—Galantamine—Alzheimer's disease	0.000557	0.00288	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000555	0.00287	CcSEcCtD
Ranolazine—Haematuria—Rivastigmine—Alzheimer's disease	0.000551	0.00285	CcSEcCtD
Ranolazine—Dry mouth—Galantamine—Alzheimer's disease	0.000547	0.00283	CcSEcCtD
Ranolazine—Epistaxis—Rivastigmine—Alzheimer's disease	0.000546	0.00282	CcSEcCtD
Ranolazine—Tinnitus—Donepezil—Alzheimer's disease	0.000545	0.00282	CcSEcCtD
Ranolazine—Confusional state—Galantamine—Alzheimer's disease	0.00054	0.00279	CcSEcCtD
Ranolazine—Bradycardia—Memantine—Alzheimer's disease	0.00054	0.00279	CcSEcCtD
Ranolazine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000529	0.00273	CcSEcCtD
Ranolazine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000528	0.00273	CcSEcCtD
Ranolazine—Hallucination—Memantine—Alzheimer's disease	0.000528	0.00273	CcSEcCtD
Ranolazine—Shock—Galantamine—Alzheimer's disease	0.000527	0.00273	CcSEcCtD
Ranolazine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000526	0.00272	CcSEcCtD
Ranolazine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000525	0.00271	CcSEcCtD
Ranolazine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000524	0.00271	CcSEcCtD
Ranolazine—Oedema peripheral—Memantine—Alzheimer's disease	0.000523	0.0027	CcSEcCtD
Ranolazine—Arrhythmia—Donepezil—Alzheimer's disease	0.000522	0.0027	CcSEcCtD
Ranolazine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000522	0.0027	CcSEcCtD
Ranolazine—Skin disorder—Galantamine—Alzheimer's disease	0.000521	0.00269	CcSEcCtD
Ranolazine—Urethral disorder—Memantine—Alzheimer's disease	0.00052	0.00269	CcSEcCtD
Ranolazine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000518	0.00268	CcSEcCtD
Ranolazine—Hallucination—Rivastigmine—Alzheimer's disease	0.000517	0.00267	CcSEcCtD
Ranolazine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000517	0.00267	CcSEcCtD
Ranolazine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000513	0.00265	CcSEcCtD
Ranolazine—Mental disorder—Donepezil—Alzheimer's disease	0.000512	0.00265	CcSEcCtD
Ranolazine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000511	0.00265	CcSEcCtD
Ranolazine—Visual impairment—Memantine—Alzheimer's disease	0.000511	0.00265	CcSEcCtD
Ranolazine—Anorexia—Galantamine—Alzheimer's disease	0.000511	0.00264	CcSEcCtD
Ranolazine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00051	0.00264	CcSEcCtD
Ranolazine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000509	0.00263	CcSEcCtD
Ranolazine—Malnutrition—Donepezil—Alzheimer's disease	0.000509	0.00263	CcSEcCtD
Ranolazine—Flatulence—Donepezil—Alzheimer's disease	0.000501	0.00259	CcSEcCtD
Ranolazine—Hypotension—Galantamine—Alzheimer's disease	0.000501	0.00259	CcSEcCtD
Ranolazine—Visual impairment—Rivastigmine—Alzheimer's disease	0.0005	0.00259	CcSEcCtD
Ranolazine—Eye disorder—Memantine—Alzheimer's disease	0.000496	0.00257	CcSEcCtD
Ranolazine—Tinnitus—Memantine—Alzheimer's disease	0.000495	0.00256	CcSEcCtD
Ranolazine—Cardiac disorder—Memantine—Alzheimer's disease	0.000493	0.00255	CcSEcCtD
Ranolazine—Muscle spasms—Donepezil—Alzheimer's disease	0.000489	0.00253	CcSEcCtD
Ranolazine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000485	0.00251	CcSEcCtD
Ranolazine—Insomnia—Galantamine—Alzheimer's disease	0.000485	0.00251	CcSEcCtD
Ranolazine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000484	0.0025	CcSEcCtD
Ranolazine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000482	0.00249	CcSEcCtD
Ranolazine—Angiopathy—Memantine—Alzheimer's disease	0.000482	0.00249	CcSEcCtD
Ranolazine—Paraesthesia—Galantamine—Alzheimer's disease	0.000481	0.00249	CcSEcCtD
Ranolazine—Vision blurred—Donepezil—Alzheimer's disease	0.00048	0.00248	CcSEcCtD
Ranolazine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000478	0.00247	CcSEcCtD
Ranolazine—Tremor—Donepezil—Alzheimer's disease	0.000477	0.00247	CcSEcCtD
Ranolazine—Somnolence—Galantamine—Alzheimer's disease	0.000476	0.00246	CcSEcCtD
Ranolazine—Arrhythmia—Memantine—Alzheimer's disease	0.000474	0.00245	CcSEcCtD
Ranolazine—Dyspepsia—Galantamine—Alzheimer's disease	0.000472	0.00244	CcSEcCtD
Ranolazine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000471	0.00244	CcSEcCtD
Ranolazine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000468	0.00242	CcSEcCtD
Ranolazine—Decreased appetite—Galantamine—Alzheimer's disease	0.000466	0.00241	CcSEcCtD
Ranolazine—Mental disorder—Memantine—Alzheimer's disease	0.000465	0.0024	CcSEcCtD
Ranolazine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000464	0.0024	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000463	0.00239	CcSEcCtD
Ranolazine—Malnutrition—Memantine—Alzheimer's disease	0.000462	0.00239	CcSEcCtD
Ranolazine—Fatigue—Galantamine—Alzheimer's disease	0.000462	0.00239	CcSEcCtD
Ranolazine—Constipation—Galantamine—Alzheimer's disease	0.000458	0.00237	CcSEcCtD
Ranolazine—Vertigo—Donepezil—Alzheimer's disease	0.000457	0.00236	CcSEcCtD
Ranolazine—Syncope—Donepezil—Alzheimer's disease	0.000456	0.00236	CcSEcCtD
Ranolazine—Flatulence—Memantine—Alzheimer's disease	0.000455	0.00235	CcSEcCtD
Ranolazine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000455	0.00235	CcSEcCtD
Ranolazine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000452	0.00234	CcSEcCtD
Ranolazine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000447	0.00231	CcSEcCtD
Ranolazine—Flatulence—Rivastigmine—Alzheimer's disease	0.000445	0.0023	CcSEcCtD
Ranolazine—Bupivacaine—CYP2D6—Alzheimer's disease	0.000444	0.207	CrCbGaD
Ranolazine—Cough—Donepezil—Alzheimer's disease	0.000444	0.0023	CcSEcCtD
Ranolazine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000442	0.00228	CcSEcCtD
Ranolazine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000438	0.00227	CcSEcCtD
Ranolazine—Vision blurred—Memantine—Alzheimer's disease	0.000435	0.00225	CcSEcCtD
Ranolazine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000435	0.00225	CcSEcCtD
Ranolazine—Tremor—Memantine—Alzheimer's disease	0.000433	0.00224	CcSEcCtD
Ranolazine—Anxiety—Donepezil—Alzheimer's disease	0.000432	0.00223	CcSEcCtD
Ranolazine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000426	0.0022	CcSEcCtD
Ranolazine—Dry mouth—Donepezil—Alzheimer's disease	0.000424	0.00219	CcSEcCtD
Ranolazine—Abdominal pain—Galantamine—Alzheimer's disease	0.000424	0.00219	CcSEcCtD
Ranolazine—Tremor—Rivastigmine—Alzheimer's disease	0.000423	0.00219	CcSEcCtD
Ranolazine—SCN5A—L1CAM interactions—DPYSL2—Alzheimer's disease	0.000421	0.0223	CbGpPWpGaD
Ranolazine—Confusional state—Donepezil—Alzheimer's disease	0.000419	0.00217	CcSEcCtD
Ranolazine—Vertigo—Memantine—Alzheimer's disease	0.000415	0.00215	CcSEcCtD
Ranolazine—Syncope—Memantine—Alzheimer's disease	0.000414	0.00214	CcSEcCtD
Ranolazine—Leukopenia—Memantine—Alzheimer's disease	0.000414	0.00214	CcSEcCtD
Ranolazine—Shock—Donepezil—Alzheimer's disease	0.000409	0.00211	CcSEcCtD
Ranolazine—Palpitations—Memantine—Alzheimer's disease	0.000408	0.00211	CcSEcCtD
Ranolazine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000407	0.00211	CcSEcCtD
Ranolazine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000407	0.0021	CcSEcCtD
Ranolazine—Vertigo—Rivastigmine—Alzheimer's disease	0.000406	0.0021	CcSEcCtD
Ranolazine—Loss of consciousness—Memantine—Alzheimer's disease	0.000406	0.0021	CcSEcCtD
Ranolazine—Syncope—Rivastigmine—Alzheimer's disease	0.000405	0.0021	CcSEcCtD
Ranolazine—Cough—Memantine—Alzheimer's disease	0.000403	0.00209	CcSEcCtD
Ranolazine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000401	0.00208	CcSEcCtD
Ranolazine—Palpitations—Rivastigmine—Alzheimer's disease	0.000399	0.00207	CcSEcCtD
Ranolazine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000397	0.00205	CcSEcCtD
Ranolazine—Anorexia—Donepezil—Alzheimer's disease	0.000396	0.00205	CcSEcCtD
Ranolazine—Cough—Rivastigmine—Alzheimer's disease	0.000394	0.00204	CcSEcCtD
Ranolazine—Anxiety—Memantine—Alzheimer's disease	0.000392	0.00203	CcSEcCtD
Ranolazine—Hypotension—Donepezil—Alzheimer's disease	0.000388	0.00201	CcSEcCtD
Ranolazine—Dry mouth—Memantine—Alzheimer's disease	0.000385	0.00199	CcSEcCtD
Ranolazine—Asthenia—Galantamine—Alzheimer's disease	0.000384	0.00199	CcSEcCtD
Ranolazine—Anxiety—Rivastigmine—Alzheimer's disease	0.000383	0.00198	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000382	0.00198	CcSEcCtD
Ranolazine—Confusional state—Memantine—Alzheimer's disease	0.00038	0.00197	CcSEcCtD
Ranolazine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000376	0.00195	CcSEcCtD
Ranolazine—Insomnia—Donepezil—Alzheimer's disease	0.000376	0.00194	CcSEcCtD
Ranolazine—Paraesthesia—Donepezil—Alzheimer's disease	0.000373	0.00193	CcSEcCtD
Ranolazine—Confusional state—Rivastigmine—Alzheimer's disease	0.000372	0.00192	CcSEcCtD
Ranolazine—Shock—Memantine—Alzheimer's disease	0.000371	0.00192	CcSEcCtD
Ranolazine—Dyspnoea—Donepezil—Alzheimer's disease	0.00037	0.00191	CcSEcCtD
Ranolazine—Nervous system disorder—Memantine—Alzheimer's disease	0.00037	0.00191	CcSEcCtD
Ranolazine—Somnolence—Donepezil—Alzheimer's disease	0.000369	0.00191	CcSEcCtD
Ranolazine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000369	0.00191	CcSEcCtD
Ranolazine—Skin disorder—Memantine—Alzheimer's disease	0.000366	0.00189	CcSEcCtD
Ranolazine—Dyspepsia—Donepezil—Alzheimer's disease	0.000366	0.00189	CcSEcCtD
Ranolazine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000365	0.00189	CcSEcCtD
Ranolazine—Shock—Rivastigmine—Alzheimer's disease	0.000363	0.00188	CcSEcCtD
Ranolazine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000362	0.00187	CcSEcCtD
Ranolazine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000361	0.00187	CcSEcCtD
Ranolazine—Decreased appetite—Donepezil—Alzheimer's disease	0.000361	0.00187	CcSEcCtD
Ranolazine—Anorexia—Memantine—Alzheimer's disease	0.000359	0.00186	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000359	0.00185	CcSEcCtD
Ranolazine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000358	0.00185	CcSEcCtD
Ranolazine—Fatigue—Donepezil—Alzheimer's disease	0.000358	0.00185	CcSEcCtD
Ranolazine—Ropivacaine—CYP2D6—Alzheimer's disease	0.000358	0.167	CrCbGaD
Ranolazine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000357	0.00184	CcSEcCtD
Ranolazine—Constipation—Donepezil—Alzheimer's disease	0.000355	0.00184	CcSEcCtD
Ranolazine—Dizziness—Galantamine—Alzheimer's disease	0.000354	0.00183	CcSEcCtD
Ranolazine—Hypotension—Memantine—Alzheimer's disease	0.000352	0.00182	CcSEcCtD
Ranolazine—Anorexia—Rivastigmine—Alzheimer's disease	0.000352	0.00182	CcSEcCtD
Ranolazine—Hypotension—Rivastigmine—Alzheimer's disease	0.000345	0.00178	CcSEcCtD
Ranolazine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000342	0.00177	CcSEcCtD
Ranolazine—Insomnia—Memantine—Alzheimer's disease	0.000341	0.00176	CcSEcCtD
Ranolazine—Vomiting—Galantamine—Alzheimer's disease	0.000341	0.00176	CcSEcCtD
Ranolazine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00034	0.00176	CcSEcCtD
Ranolazine—Paraesthesia—Memantine—Alzheimer's disease	0.000339	0.00175	CcSEcCtD
Ranolazine—Rash—Galantamine—Alzheimer's disease	0.000338	0.00175	CcSEcCtD
Ranolazine—Dermatitis—Galantamine—Alzheimer's disease	0.000338	0.00175	CcSEcCtD
Ranolazine—Dyspnoea—Memantine—Alzheimer's disease	0.000336	0.00174	CcSEcCtD
Ranolazine—Headache—Galantamine—Alzheimer's disease	0.000336	0.00174	CcSEcCtD
Ranolazine—Somnolence—Memantine—Alzheimer's disease	0.000335	0.00173	CcSEcCtD
Ranolazine—Insomnia—Rivastigmine—Alzheimer's disease	0.000334	0.00173	CcSEcCtD
Ranolazine—Dyspepsia—Memantine—Alzheimer's disease	0.000332	0.00172	CcSEcCtD
Ranolazine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000331	0.00171	CcSEcCtD
Ranolazine—Urticaria—Donepezil—Alzheimer's disease	0.00033	0.00171	CcSEcCtD
Ranolazine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000329	0.0017	CcSEcCtD
Ranolazine—Abdominal pain—Donepezil—Alzheimer's disease	0.000328	0.0017	CcSEcCtD
Ranolazine—Carvedilol—PTGS1—Alzheimer's disease	0.000328	0.153	CrCbGaD
Ranolazine—Somnolence—Rivastigmine—Alzheimer's disease	0.000328	0.0017	CcSEcCtD
Ranolazine—Decreased appetite—Memantine—Alzheimer's disease	0.000328	0.0017	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000326	0.00168	CcSEcCtD
Ranolazine—Fatigue—Memantine—Alzheimer's disease	0.000325	0.00168	CcSEcCtD
Ranolazine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000325	0.00168	CcSEcCtD
Ranolazine—CYP2D6—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.000324	0.0171	CbGpPWpGaD
Ranolazine—Constipation—Memantine—Alzheimer's disease	0.000322	0.00167	CcSEcCtD
Ranolazine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000321	0.00166	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—TREM2—Alzheimer's disease	0.00032	0.0169	CbGpPWpGaD
Ranolazine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000318	0.00165	CcSEcCtD
Ranolazine—Nausea—Galantamine—Alzheimer's disease	0.000318	0.00165	CcSEcCtD
Ranolazine—Fatigue—Rivastigmine—Alzheimer's disease	0.000318	0.00164	CcSEcCtD
Ranolazine—Constipation—Rivastigmine—Alzheimer's disease	0.000315	0.00163	CcSEcCtD
Ranolazine—Feeling abnormal—Memantine—Alzheimer's disease	0.000311	0.00161	CcSEcCtD
Ranolazine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000308	0.00159	CcSEcCtD
Ranolazine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.000306	0.0162	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—DLG4—Alzheimer's disease	0.000305	0.0162	CbGpPWpGaD
Ranolazine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000304	0.00157	CcSEcCtD
Ranolazine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000302	0.00156	CcSEcCtD
Ranolazine—Urticaria—Memantine—Alzheimer's disease	0.0003	0.00155	CcSEcCtD
Ranolazine—Abdominal pain—Memantine—Alzheimer's disease	0.000298	0.00154	CcSEcCtD
Ranolazine—Asthenia—Donepezil—Alzheimer's disease	0.000298	0.00154	CcSEcCtD
Ranolazine—Pruritus—Donepezil—Alzheimer's disease	0.000294	0.00152	CcSEcCtD
Ranolazine—Urticaria—Rivastigmine—Alzheimer's disease	0.000293	0.00152	CcSEcCtD
Ranolazine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000292	0.00151	CcSEcCtD
Ranolazine—Dizziness—Donepezil—Alzheimer's disease	0.000275	0.00142	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000271	0.0143	CbGpPWpGaD
Ranolazine—Asthenia—Memantine—Alzheimer's disease	0.000271	0.0014	CcSEcCtD
Ranolazine—Pruritus—Memantine—Alzheimer's disease	0.000267	0.00138	CcSEcCtD
Ranolazine—Asthenia—Rivastigmine—Alzheimer's disease	0.000265	0.00137	CcSEcCtD
Ranolazine—Vomiting—Donepezil—Alzheimer's disease	0.000264	0.00137	CcSEcCtD
Ranolazine—Rash—Donepezil—Alzheimer's disease	0.000262	0.00135	CcSEcCtD
Ranolazine—Dermatitis—Donepezil—Alzheimer's disease	0.000262	0.00135	CcSEcCtD
Ranolazine—Pruritus—Rivastigmine—Alzheimer's disease	0.000261	0.00135	CcSEcCtD
Ranolazine—Headache—Donepezil—Alzheimer's disease	0.00026	0.00135	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—DPYSL2—Alzheimer's disease	0.000255	0.0135	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000255	0.0135	CbGpPWpGaD
Ranolazine—Dizziness—Memantine—Alzheimer's disease	0.000249	0.00129	CcSEcCtD
Ranolazine—Nausea—Donepezil—Alzheimer's disease	0.000247	0.00128	CcSEcCtD
Ranolazine—Dizziness—Rivastigmine—Alzheimer's disease	0.000244	0.00126	CcSEcCtD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—IGF2—Alzheimer's disease	0.000243	0.0128	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—EPHA1—Alzheimer's disease	0.000242	0.0128	CbGpPWpGaD
Ranolazine—Vomiting—Memantine—Alzheimer's disease	0.00024	0.00124	CcSEcCtD
Ranolazine—Rash—Memantine—Alzheimer's disease	0.000238	0.00123	CcSEcCtD
Ranolazine—Dermatitis—Memantine—Alzheimer's disease	0.000238	0.00123	CcSEcCtD
Ranolazine—Headache—Memantine—Alzheimer's disease	0.000236	0.00122	CcSEcCtD
Ranolazine—Vomiting—Rivastigmine—Alzheimer's disease	0.000235	0.00121	CcSEcCtD
Ranolazine—Rash—Rivastigmine—Alzheimer's disease	0.000233	0.0012	CcSEcCtD
Ranolazine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000232	0.0012	CcSEcCtD
Ranolazine—Headache—Rivastigmine—Alzheimer's disease	0.000231	0.0012	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00023	0.0122	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00023	0.0122	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TREM2—Alzheimer's disease	0.000228	0.0121	CbGpPWpGaD
Ranolazine—Nausea—Memantine—Alzheimer's disease	0.000224	0.00116	CcSEcCtD
Ranolazine—Carvedilol—CYP2D6—Alzheimer's disease	0.000223	0.104	CrCbGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—MEF2C—Alzheimer's disease	0.000223	0.0118	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000223	0.0118	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—CDK5—Alzheimer's disease	0.000221	0.0117	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00022	0.0116	CbGpPWpGaD
Ranolazine—Nausea—Rivastigmine—Alzheimer's disease	0.000219	0.00113	CcSEcCtD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00021	0.0111	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000208	0.011	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—TREM2—Alzheimer's disease	0.000199	0.0105	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000196	0.0104	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—PSENEN—Alzheimer's disease	0.000194	0.0102	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—APH1A—Alzheimer's disease	0.000191	0.0101	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—DLG4—Alzheimer's disease	0.00019	0.0101	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—NCSTN—Alzheimer's disease	0.000186	0.00983	CbGpPWpGaD
Ranolazine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000185	0.00979	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000184	0.00973	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—DPYSL2—Alzheimer's disease	0.000182	0.00964	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.000182	0.0096	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000181	0.00955	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000177	0.00934	CbGpPWpGaD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000176	0.00928	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—Alzheimer's disease	0.000174	0.00921	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EPHA1—Alzheimer's disease	0.000173	0.00914	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000171	0.00902	CbGpPWpGaD
Ranolazine—Propranolol—CYP2D6—Alzheimer's disease	0.00017	0.0792	CrCbGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000165	0.00874	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—GSK3B—Alzheimer's disease	0.000163	0.00864	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—INS—Alzheimer's disease	0.000161	0.00852	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—DPYSL2—Alzheimer's disease	0.000159	0.00842	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CDK5—Alzheimer's disease	0.000158	0.00836	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—PRNP—Alzheimer's disease	0.000156	0.00825	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—IGF1—Alzheimer's disease	0.000156	0.00824	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—PSEN2—Alzheimer's disease	0.000151	0.00799	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—EPHA1—Alzheimer's disease	0.000151	0.00798	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.00015	0.00793	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000148	0.00784	CbGpPWpGaD
Ranolazine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000147	0.00777	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TREM2—Alzheimer's disease	0.000142	0.00751	CbGpPWpGaD
Ranolazine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000141	0.00747	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000139	0.00738	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PSENEN—Alzheimer's disease	0.000138	0.00731	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—CDK5—Alzheimer's disease	0.000138	0.0073	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000138	0.00727	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—APH1A—Alzheimer's disease	0.000136	0.0072	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000136	0.00718	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000136	0.00717	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000136	0.00717	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NCSTN—Alzheimer's disease	0.000133	0.00701	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—PSENEN—Alzheimer's disease	0.000121	0.00638	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—APH1A—Alzheimer's disease	0.000119	0.00629	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—NCSTN—Alzheimer's disease	0.000116	0.00612	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—DLG4—Alzheimer's disease	0.000115	0.0061	CbGpPWpGaD
Ranolazine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000114	0.00605	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—DPYSL2—Alzheimer's disease	0.000114	0.00601	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—GRIN2B—Alzheimer's disease	0.000113	0.00597	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000111	0.0059	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PRNP—Alzheimer's disease	0.000111	0.00589	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PSEN2—Alzheimer's disease	0.000108	0.0057	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EPHA1—Alzheimer's disease	0.000108	0.00569	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000104	0.00551	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000102	0.00538	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—ADAM10—Alzheimer's disease	0.000102	0.00538	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000101	0.00537	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000101	0.00535	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IAPP—Alzheimer's disease	9.86e-05	0.00522	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CDK5—Alzheimer's disease	9.85e-05	0.00521	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	9.72e-05	0.00514	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—PRNP—Alzheimer's disease	9.72e-05	0.00514	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—CALM1—Alzheimer's disease	9.55e-05	0.00505	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—APOE—Alzheimer's disease	9.52e-05	0.00503	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—PSEN2—Alzheimer's disease	9.41e-05	0.00498	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	9.4e-05	0.00497	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—Alzheimer's disease	9.34e-05	0.00494	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP46A1—Alzheimer's disease	9.06e-05	0.00479	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	8.99e-05	0.00475	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP46A1—Alzheimer's disease	8.93e-05	0.00472	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PSENEN—Alzheimer's disease	8.61e-05	0.00455	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	8.55e-05	0.00452	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—APH1A—Alzheimer's disease	8.49e-05	0.00449	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	8.33e-05	0.0044	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NCSTN—Alzheimer's disease	8.26e-05	0.00437	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	8.24e-05	0.00436	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—DLG4—Alzheimer's disease	8.24e-05	0.00436	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—GRIN2B—Alzheimer's disease	8.05e-05	0.00426	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.71e-05	0.00408	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	7.53e-05	0.00399	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ADAM10—Alzheimer's disease	7.26e-05	0.00384	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—DLG4—Alzheimer's disease	7.19e-05	0.0038	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—GRIN2B—Alzheimer's disease	7.03e-05	0.00372	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PRNP—Alzheimer's disease	6.94e-05	0.00367	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	6.83e-05	0.00361	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PSEN2—Alzheimer's disease	6.72e-05	0.00355	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PPARGC1A—Alzheimer's disease	6.65e-05	0.00352	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	6.65e-05	0.00352	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ADAM10—Alzheimer's disease	6.33e-05	0.00335	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—GSK3B—Alzheimer's disease	6.16e-05	0.00326	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IAPP—Alzheimer's disease	6.14e-05	0.00325	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—CREB1—Alzheimer's disease	6.11e-05	0.00323	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	6.1e-05	0.00323	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—LPL—Alzheimer's disease	6.06e-05	0.0032	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	6.02e-05	0.00318	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MEF2C—Alzheimer's disease	6e-05	0.00317	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	5.92e-05	0.00313	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	5.84e-05	0.00309	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	5.4e-05	0.00286	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—DLG4—Alzheimer's disease	5.13e-05	0.00271	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—LEP—Alzheimer's disease	5.08e-05	0.00268	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	5.07e-05	0.00268	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	5.06e-05	0.00268	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	5.04e-05	0.00267	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—GRIN2B—Alzheimer's disease	5.02e-05	0.00265	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	4.94e-05	0.00261	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	4.77e-05	0.00252	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NOTCH1—Alzheimer's disease	4.69e-05	0.00248	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ADAM10—Alzheimer's disease	4.52e-05	0.00239	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PPARG—Alzheimer's disease	4.42e-05	0.00234	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—GSK3B—Alzheimer's disease	4.4e-05	0.00233	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CREB1—Alzheimer's disease	4.36e-05	0.00231	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—INS—Alzheimer's disease	4.34e-05	0.00229	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	4.29e-05	0.00227	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PPARGC1A—Alzheimer's disease	4.14e-05	0.00219	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	4.1e-05	0.00217	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—VEGFA—Alzheimer's disease	3.84e-05	0.00203	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—GSK3B—Alzheimer's disease	3.84e-05	0.00203	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—CREB1—Alzheimer's disease	3.81e-05	0.00201	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—LPL—Alzheimer's disease	3.77e-05	0.002	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MEF2C—Alzheimer's disease	3.74e-05	0.00198	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	3.68e-05	0.00195	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.53e-05	0.00187	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—LEP—Alzheimer's disease	3.16e-05	0.00167	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.97e-05	0.00157	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NOTCH1—Alzheimer's disease	2.92e-05	0.00154	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PPARG—Alzheimer's disease	2.75e-05	0.00146	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—VEGFA—Alzheimer's disease	2.74e-05	0.00145	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—GSK3B—Alzheimer's disease	2.74e-05	0.00145	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CREB1—Alzheimer's disease	2.72e-05	0.00144	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—INS—Alzheimer's disease	2.7e-05	0.00143	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.68e-05	0.00142	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6—Alzheimer's disease	2.66e-05	0.0014	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.63e-05	0.00139	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.59e-05	0.00137	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TGFB1—Alzheimer's disease	2.51e-05	0.00133	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—VEGFA—Alzheimer's disease	2.39e-05	0.00127	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TNF—Alzheimer's disease	2.35e-05	0.00124	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.32e-05	0.00123	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.97e-05	0.00104	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—Alzheimer's disease	1.9e-05	0.001	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.86e-05	0.000982	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.76e-05	0.00093	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT1—Alzheimer's disease	1.75e-05	0.000925	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—Alzheimer's disease	1.71e-05	0.000903	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.68e-05	0.000888	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—Alzheimer's disease	1.65e-05	0.000875	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.61e-05	0.000851	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TGFB1—Alzheimer's disease	1.57e-05	0.000829	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.55e-05	0.000819	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.52e-05	0.000803	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.5e-05	0.000791	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TNF—Alzheimer's disease	1.46e-05	0.000774	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.29e-05	0.000683	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.21e-05	0.000642	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—Alzheimer's disease	1.18e-05	0.000624	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.15e-05	0.000608	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.1e-05	0.00058	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT1—Alzheimer's disease	1.09e-05	0.000576	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.05e-05	0.000556	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.01e-05	0.000536	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ND1—Alzheimer's disease	9.78e-06	0.000517	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	9.64e-06	0.00051	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	9.64e-06	0.00051	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.24e-06	0.000489	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	8.9e-06	0.00047	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—A2M—Alzheimer's disease	8.59e-06	0.000454	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.47e-06	0.000395	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.39e-06	0.000391	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7e-06	0.00037	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7e-06	0.00037	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.51e-06	0.000344	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.3e-06	0.000333	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.3e-06	0.000333	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.14e-06	0.000325	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.04e-06	0.00032	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.96e-06	0.000315	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.82e-06	0.000308	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.62e-06	0.000297	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.13e-06	0.000271	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.11e-06	0.00027	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.89e-06	0.000258	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.83e-06	0.000255	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.67e-06	0.000247	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.58e-06	0.000242	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.58e-06	0.000242	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.49e-06	0.000238	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.26e-06	0.000225	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.21e-06	0.000223	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.02e-06	0.000212	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.93e-06	0.000208	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.92e-06	0.000207	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.89e-06	0.000206	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.88e-06	0.000205	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.41e-06	0.00018	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.36e-06	0.000177	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—INS—Alzheimer's disease	3.35e-06	0.000177	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.34e-06	0.000177	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.06e-06	0.000162	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.93e-06	0.000155	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.75e-06	0.000145	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.68e-06	0.000142	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.57e-06	0.000136	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.56e-06	0.000135	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.54e-06	0.000134	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.23e-06	0.000118	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.19e-06	0.000116	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.92e-06	0.000101	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.75e-06	9.28e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.35e-06	7.13e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.82e-07	4.66e-05	CbGpPWpGaD
